Feb 23, 2021
Applied Therapeutics to Present at the Cowen and Barclays Investor Conferences
NEW YORK, Feb. 23, 2021 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, announced today that it will present at two
Feb 22, 2021
Applied Therapeutics, Inc. Announces Closing of Public Offering
NEW YORK, Feb. 22, 2021 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (NASDAQ: APLT) (the “Company”), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced the closing
Feb 01, 2021
Applied Therapeutics Announces Restart of Pediatric Galactosemia Study
FDA Clinical Hold Lifted NEW YORK, Feb. 01, 2021 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced


Print Page
Print Page
Email Alerts
RSS Feeds
RSS Feeds
Contact IR
Contact IR
AP_logo_KO
linkedin
facebook
twitter

©2021 Applied Therapeutics All Rights Reserved

linkedin
facebook
twitter
AP_logo_KO

©2021 Applied Therapeutics All Rights Reserved